Millions Logo
home>US Stocks>Horizon Technology Finance
HRZN
Horizon Technology FinanceFinancial Services
$3.77$-3.04 (-44.71%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $3.6152 Week High: $6.85

Horizon Technology Finance Share Price Today

Horizon Technology Finance opened lower at $3.76, compared with its previous close of $3.79. In the last trading session, the stock traded between $3.71 and $3.79. It showed a sideways intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in Horizon Technology Finance is now worth

$ 21.33

Resulting in a loss of

$ 78.67 (78.67%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Hold

Rating from 6 Analysts

Buy
33.33%
Hold
66.67%
Sell
0%

Markets Today

Today's Change

$-0.02 (-0.53%)

Day High

$3.79

Day Low

$3.71

Day Open

$3.76

Prev Close

$3.79

Volume

4,41,378

1W Return

-6.69%

1M Return

-17.88%

3M Return

-22.93%

6M Return

-13.05%

1Y Return

-44.71%

Fundamentals

Market Cap ($ Mn)

245

PE Ratio

16.24

PB Ratio

0.76

PEG Ratio

-

ROE

-0.85%

ROCE

-

EPS (TTM)

$-0.43

Investment Returns

1 Week

-6.69%

1 Month

-17.88%

3 Months

-22.93%

6 Months

-13.05%

9 Months

-43.21%

Financials

Quarterly
All values in $ Mn
-7.6

Mar 25
-6.9

Jun 25
44.3

Sep 25
22.0

Dec 25
-19.6

Jun 26
-16.5

Sep 26

Updates

11Nov

UBS cuts Horizon Tech price target to $3.75, keeps neutral rating

UBS lowers Horizon Tech price target to $3.75 from $4.50 while maintaining Neutral rating. Q3FY26 NAV per share fell to $5.56, down $0.67 sequentially due to write-downs. Net investment income per share dropped 40.6% YoY to $0.19 despite portfolio growth. Debt portfolio yield contracted to 14.7% from 18.6% in Q3FY25.

2 days ago
3Sep

Horizon Technology Finance provides $15 million loan facility to Bioness Medical

Horizon Technology Finance provided a $15 million senior credit facility to Bioness Medical, Inc. An initial $10 million was funded at closing, with up to $5 million available for future growth support. Bioness Medical develops FDA-approved neurorehabilitation technologies, backed by Accelmed Partners, serving hospital, outpatient, and home-based care settings. The facility is intended to support Bioness's innovation investment and product portfolio expansion. Horizon Technology Finance is headquartered in Farmington, Connecticut, and is an affiliate of Monroe Capital.

2mo ago
22Jul

Horizon Technology Finance to announce Q2FY26 results on August 4

Horizon Technology Finance Corporation will announce its Q2FY26 financial results on August 4, 2026, followed by a conference call on August 5, 2026, led by senior executives including CEO Mike Balkin.

3mo ago

Similar Stocks

StockLTPChange %Market CapPE
$1,226.31+0.34%$1,89,370.47M27.87
$42.06-0.78%$93,889.11M76.54
$122.01-0.42%$91,643.54M31.85
$100.05-0.79%$89,258.61M34.72
$52.56-1.74%$83,950.41M29.95
$122.95+0.17%$72,593.74M48.40
$174.17+1.49%$47,387.83M17.05
$520.06+0.02%$45,147.45M13.50
$178.71+0.46%$32,367.60M16.05
$167.13-0.58%$32,088.96M15.64
$137.89-1.09%$30,881.57M65.68
$114.69-1.12%$24,357.40M15.87